06/07/2021
4:30 PM | CASI Pharmaceuticals (Filer)
| Form DEFA14A
| |
05/13/2021
8:45 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2021
10:33 AM | CASI Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/30/2021
3:52 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/30/2021
3:50 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2021
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/23/2021
4:18 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
03/12/2021
8:20 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/17/2021
2:09 PM | CASI Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
| Form SC 13G
| |
02/16/2021
1:20 PM | CASI Pharmaceuticals (Subject)
Consonance Capital Management LP (Filed by)
| Form SC 13G
| |
|
02/12/2021
2:01 PM | CASI Pharmaceuticals (Subject)
FEDERATED HERMES, INC. (Filed by)
| Form SC 13G
| |
02/10/2021
4:29 PM | CASI Pharmaceuticals (Filer)
| Form 10-Q/A
| |
02/10/2021
4:04 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/28/2021
3:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/23/2020
3:02 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/23/2020
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2020
3:05 PM | CASI Pharmaceuticals (Issuer)
Xu Weihao (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2020
3:05 PM | CASI Pharmaceuticals (Issuer)
Xu Weihao (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/16/2020
3:43 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/02/2020
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
11/24/2020
4:39 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2020
3:06 PM | CASI Pharmaceuticals (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/09/2020
3:30 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2020
1:39 PM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/28/2020
3:26 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/28/2020
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/02/2020
3:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/19/2020
3:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/18/2020
3:04 PM | CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
| Form SC 13D/A
| |
08/10/2020
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/10/2020
11:51 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
07/29/2020
4:16 PM | CASI Pharmaceuticals (Subject)
He Wei-Wu (Filed by)
| Form SC 13D/A
| |
07/24/2020
3:05 PM | CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2020
3:05 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2020
3:18 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
07/21/2020
3:13 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/21/2020
3:13 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
06/18/2020
5:07 AM | CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
5:05 AM | CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
5:04 AM | CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
5:03 AM | CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2020
5:02 AM | CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2020
4:14 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2020
4:55 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/11/2020
2:31 PM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/22/2020
8:45 AM | CASI Pharmaceuticals (Filer)
| Form DEF 14A
| |
03/19/2020
4:39 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2020
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/16/2020
2:01 PM | CASI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2020
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2019
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/12/2019
10:01 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/12/2019
9:01 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2019
3:51 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/25/2019
3:02 PM | CASI Pharmaceuticals (Filer)
| Form 8-K/A
| |
09/24/2019
3:04 PM | CASI Pharmaceuticals (Issuer)
Zhang Larry (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2019
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/23/2019
4:25 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/20/2019
3:30 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2019
10:03 AM | CASI Pharmaceuticals (Filer)
| Form CT ORDER
| |
08/15/2019
3:51 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2019
3:31 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
08/09/2019
9:01 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2019
4:01 PM | CASI Pharmaceuticals (Filer)
| Form 424B5
| |
07/19/2019
4:00 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Wu Yue Alexander (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Salisbury Franklin Cary jr (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Huang James (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
SHROTRIYA RAJESH C MD (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2019
4:01 PM | CASI Pharmaceuticals (Issuer)
Zhou Quan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2019
3:01 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2019
12:35 PM | CASI Pharmaceuticals (Filer)
| Form CT ORDER
| |
05/15/2019
9:03 AM | CASI Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/15/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2019
3:50 PM | CASI Pharmaceuticals (Filer)
| Form DEF 14A
| |
04/17/2019
3:03 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2019
3:01 PM | CASI Pharmaceuticals (Subject)
SPECTRUM PHARMACEUTICALS INC (Filed by)
| Form SC 13D/A
| |
04/05/2019
3:31 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/05/2019
3:02 PM | CASI Pharmaceuticals (Filer)
| Form PRE 14A
| |
04/04/2019
6:30 PM | CASI Pharmaceuticals (Issuer)
Spectrum Pharmaceuticals Cayman, L.P. (Reporting)
SPECTRUM PHARMACEUTICALS INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
9:22 AM | CASI Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/29/2019
8:00 AM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/18/2019
4:02 PM | CASI Pharmaceuticals (Filer)
| Form NT 10-K
| |
03/13/2019
4:18 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/19/2019
4:23 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/06/2019
3:07 PM | CASI Pharmaceuticals (Subject)
Zhejiang Kanglaite Group Co., LTD (Filed by)
| Form SC 13G/A
| |
02/06/2019
3:06 PM | CASI Pharmaceuticals (Subject)
Li Dapeng (Filed by)
| Form SC 13G
| |
02/06/2019
3:04 PM | CASI Pharmaceuticals (Issuer)
Li Dapeng (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
01/31/2019
6:21 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/31/2019
6:19 PM | CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2019
3:46 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/15/2019
3:02 PM | CASI Pharmaceuticals (Issuer)
Hu Cynthia W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
4:00 PM | CASI Pharmaceuticals (Issuer)
He Wei-Wu (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/21/2018
3:31 PM | CASI Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/06/2018
3:30 PM | CASI Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2018
12:23 PM | CASI Pharmaceuticals (Issuer)
Ren Ken Keyong (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2018
11:15 PM | CASI Pharmaceuticals (Filer)
| Form EFFECT
| |
